Literature DB >> 33354164

Corrigendum to "Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway".

Bo Gui1,2, Fuzhou Hua3, Jie Chen4, Zeping Xu5, Hongbin Sun6, Yanning Qian1,2.   

Abstract

[This corrects the article DOI: 10.1155/2014/451826.].
Copyright © 2020 Bo Gui et al.

Entities:  

Year:  2020        PMID: 33354164      PMCID: PMC7735821          DOI: 10.1155/2020/9649787

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


In the article titled “Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway” [1], there was an error in Figure 6. The incorrect images were presented as the representative images for the p-GSK-3β bands at the preoperative (Prep) stage and their corresponding GSK-3β bands in Figure 6. The corrected figure is shown below and is listed as Figure 1.
Figure 1

Effects of pretreatment with OA on p-GSK-3β (ser9) and GSK-3β protein expression in rats induced by partial hepatic ischemia-reperfusion (IR). Expression of p-GSK-3β (ser9) and GSK-3β protein was detected by western blot analysis (a). These bands were quantified and analyzed (b). Data are represented as mean ± SD (n = 8). ∗P < 0.05, compared with group SH. #P < 0.05, compared with group IR. < 0.05, compared with group CM.

  1 in total

1.  Protective effects of pretreatment with oleanolic acid in rats in the acute phase of hepatic ischemia-reperfusion injury: role of the PI3K/Akt pathway.

Authors:  Bo Gui; Fuzhou Hua; Jie Chen; Zeping Xu; Hongbin Sun; Yanning Qian
Journal:  Mediators Inflamm       Date:  2014-04-16       Impact factor: 4.711

  1 in total
  1 in total

1.  Retracted: Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway.

Authors:  Mediators Of Inflammation
Journal:  Mediators Inflamm       Date:  2022-04-26       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.